Membership
NLA Education and Training
Practice Tools
LipidSpin
JCL
Find a Member

News


January 19, 2022

Global think tank on the clinical considerations & management of lipoprotein(a): The top questions and answers regarding what clinicians need to know published online in Progress in Cardiovascular Disease

The outcomes of a Global think tank on the clinical considerations & management of lipoprotein(a): The top...

Read More...

December 22, 2021

FDA approves Leqvio (inclisiran), first-in-class small interfering RNA therapy for adults with clinical atherosclerotic cardiovascular disease (ASCVD) or heterozygous familial hypercholesterolemia (HeFH) who require additional lowering of LDL-Cholesterol

Novartis announced that the U.S. Food and Drug Administration (FDA) approved Leqvio (inclisiran) as an adjunct to diet...

Read More...

December 9, 2021

NLA Window to Nominate for Board Leadership Now Open

The National Lipid Association has opened the nomination window for a position on the NLA Board of Directors or Chapter...

Read More...

September 24, 2021

Congratulations to Our New Fellows of the NLA

Read More...

September 24, 2021

Lipid Measurements in the Management of CardioLipid Measurements in the Management of Cardiovascular Diseases: Scientific Statementvascular Diseases: Scientific Statement

Read More...